Cargando…
Anti-apolipoprotein A-I antibodies and paraoxonase 1 activity in Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) patients have an increased risk of atherosclerosis. Identification of at-risk patients and the pathogenesis of atherosclerosis in SLE remain elusive. Paraoxonase 1 (PON1) and anti-apolipoprotein A-I antibody (anti-Apo A-I) appear to have a potential role in prematu...
Autores principales: | Ahmed, Mohammed Mahmoud, Elserougy, Eman Mahmoud, Al-Gazzar, Iman Ibrahim, Fikry, Iman Mohamed, Habib, Dawoud Fakhry, Younes, Khaled Mohamed, Salem, Neveen Abd El-hameed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663653/ https://www.ncbi.nlm.nih.gov/pubmed/26622215 |
Ejemplares similares
-
Apolipoprotein C-III in patients with systemic lupus erythematosus
por: Martín-González, Candelaria, et al.
Publicado: (2022) -
Lymphocytic Enterocolitis in Systemic Lupus Erythematosus
por: Hegazi, Mohamed O., et al.
Publicado: (2009) -
Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus
por: Dasgupta, Sudeshna, et al.
Publicado: (2011) -
Low apolipoprotein M serum levels correlate with Systemic lupus erythematosus disease activity and apolipoprotein M gene polymorphisms with Lupus
por: Du, Wenhan, et al.
Publicado: (2017) -
Proximal Aortic Stiffness Is Increased in Systemic Lupus Erythematosus Activity in Children and Adolescents
por: El Gamal, Yehia Mohamad, et al.
Publicado: (2013)